Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.

Large crowd of anonymous people

The study reports on how commonly nine core long-COVID symptoms were diagnosed, and how this rate compared to people recovering from influenza. The nine core long-COVID symptoms, occurring 90-180 days after COVID-19 was diagnosed, comprise:

  • Abnormal breathing – 8%
  • Abdominal symptoms – 8%
  • Anxiety/depression – 15%
  • Chest/throat pain – 6%
  • Cognitive problems (‘brain fog’) – 4%
  • Fatigue – 6%
  • Headache – 5%
  • Myalgia (muscle pain) – 1.5%
  • Other pain – 7%
  • Any of the above features – 37%

Higher rates were seen if the whole 1-180 day period after COVID-19 infection was included.

Severity of infection, age, and sex affected the likelihood of long-COVID symptoms: long-COVID symptoms were more frequent in those who had been hospitalised, and they were slightly commoner in women. These factors also influenced which of the symptoms people were most likely to experience. For example, older people and men had more breathing difficulties and cognitive problems, whereas young people and women had more headaches, abdominal symptoms and anxiety/depression. Many patients had more than one long-COVID symptom, and symptoms tended to co-occur more as time progressed.

The study also looked at the same symptoms in people recovering from influenza. Long-COVID symptoms did occur after influenza, but were 1.5 times more common after COVID-19.   

This study does not explain what causes long-COVID symptoms, nor how severe they are, nor how long they will last. The results do not take into account people who had COVID-19 but were not diagnosed, e.g. because they were asymptomatic and did not get tested, nor COVID-19 survivors with long-COVID symptoms that had not been recorded in their health records. 

 

NIHR Academic Clinical Fellow, Dr Max Taquet, who led the analyses, University of Oxford, said:

‘The results confirm that a significant proportion of people, of all ages, can be affected by a range of symptoms and difficulties in the six months after COVID-19 infection. These data complement findings from self-report surveys, and show that clinicians are diagnosing patients with these symptoms. We need appropriately configured services to deal with the current and future clinical need.’

 

Professor Paul Harrison, who headed the study, Department of Psychiatry, University of Oxford, said:

‘Research of different kinds is urgently needed to understand why not everyone recovers rapidly and fully from COVID-19. We need to identify the mechanisms underlying the diverse symptoms that can affect survivors. This information will be essential if the long-term health consequences of COVID-19 are to be prevented or treated effectively.’ 

To read the full study, Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19, published in PLOS Medicine.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

‘Thinking Family’ when an adult has a serious illness

New research shows that although patient’s family details were often recorded, this information was not routinely used to help patients share their diagnosis with children.

Treating mental illness with electricity - new podcast

A new wave of treatments that stimulate the brain with electricity are showing promise on patients and in clinical trials.

The risk of seizures and epilepsy is higher after COVID than after the flu

Professor Arjune Sen, Nuffield Department of Clinical Neurosciences, on new research suggesting that though the overall risk of seizures is small, it is greater after COVID

Hours of gaming not negatively impacting wellbeing of most adolescents - new study

University of Oxford researchers found that although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.

Few mental health apps make it to real world, according to new Oxford University study

Despite enthusiasm for digital technology in addressing young people’s mental health, few effective apps have been successfully rolled out.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.